Clinical Trial Update: Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated the efficacy of extended-release tramadol for treating prescription opioid withdrawal; results have been posted after compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Withdrawal
• Substance Withdrawal Syndrome

Drugs mentioned

• Ultram ER (tramadol)

Snippet

Sponsor: Michelle Lofwall | Conditions: Substance Withdrawal Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-12-03